2011 Press Releases

Gilead and GlobeImmune Announce License and Collaboration Agreement to Develop Therapeutic Vaccine Products For Treatment of Chronic Hepatitis B Infection

Foster City, CA and Louisville, CO – October 24, 2011 – Gilead Sciences, Inc. (Nasdaq: GILD) and GlobeImmune, Inc. today announced that the companies have entered into an exclusive worldwide license and collaboration agreement for the development and commercialization of … Continue reading

GlobeImmune Promotes Jeffrey Dekker to Vice President of Finance

LOUISVILLE, Colo., Aug. 31, 2011 – GlobeImmune Inc. announced today the promotion of Jeffrey Dekker to Vice President of Finance. Mr. Dekker previously served as Controller and Senior Director Finance at GlobeImmune since joining the company in 2006. Before joining … Continue reading

GlobeImmune Reports Positive Results for Two Therapeutic Vaccines, GI-4000 and GI-6207

Oncology data to be presented at the 2011 annual meeting of the American Society of Clinical Oncology (ASCO)

Continue reading